World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
54
Citations
10059
World Ranking
15666
National Ranking
1112

Kei Yamamoto publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Kei Yamamoto sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 111 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Kei Yamamoto D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Kei Yamamoto sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 54 D-Index — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Kei Yamamoto is a researcher affiliated with the University of Tokushima in Japan, specializing in the field of medicine with a focus on surgery, oncology, pulmonary and respiratory medicine, immunology, and oral surgery. Their research encompasses several key topics including cancer immunotherapy and biomarkers, oral and maxillofacial pathology, gastric cancer management and outcomes, immune cell function and interaction, Helicobacter pylori-related gastroenterology studies, gastrointestinal tumor research and treatment, and esophageal cancer research and treatment.

Their recent papers cover a range of topics in oncology and immunology. Notable publications include:

  • "Tumor-infiltrating M2 macrophage in pretreatment biopsy sample predicts response to chemotherapy and survival in esophageal cancer" (2020, Cancer Science)
  • "PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancer" (2020, International Immunology)
  • "Frequency of Odontogenic Tumors: A Single Center Study of 1089 Cases in Japan and Literature Review" (2021, Head and Neck Pathology)
  • "Clinical importance of the expression of CD4+CD8+ T cells in renal cell carcinoma" (2020, International Immunology)
  • "The impact of ICOS+ regulatory T cells and Helicobacter pylori infection on the prognosis of patients with gastric and colorectal cancer: potential prognostic benefit of pre-operative eradication therapy" (2020, Cancer Immunology Immunotherapy)

Yamamoto frequently publishes in journals such as International Immunology, Head and Neck Pathology, Cancer Immunology Immunotherapy, Esophagus, and Gastrointestinal Endoscopy, indicating a consistent presence in specialized venues relevant to their research fields.

Their collaborative network includes regular coauthors such as Yuichiro Doki, Hisashi Wada, Yukinori Kurokawa, Katsutoshi Kokubun, and Kei Nakajima, with multiple joint publications reflecting ongoing professional relationships in their research community.

The range of subfields their work covers demonstrates an interdisciplinary approach, integrating surgical techniques with oncological and immunological studies focused on cancer and gastrointestinal diseases. This multidisciplinary focus aligns with their main research themes in cancer immunotherapy, immune interactions, and tumor biology.

Best Publications

  • Transcriptional Roles of Nuclear Factor κB and Nuclear Factor-Interleukin-6 in the Tumor Necrosis Factor α-Dependent Induction of Cyclooxygenase-2 in MC3T3-E1 Cells (∗)

    Kei Yamamoto;Toshiya Arakawa;Natsuo Ueda;Shozo Yamamoto

  • Recent progress in phospholipase A₂ research: from cells to animals to humans.

    Makoto Murakami;Yoshitaka Taketomi;Yoshimi Miki;Hiroyasu Sato

  • Endothelial Apoptosis Induced by Oxidative Stress Through Activation of NF-κB: Antiapoptotic Effect of Antioxidant Agents on Endothelial Cells

    Motokuni Aoki;Toshie Nata;Ryuichi Morishita;Hidetsugu Matsushita

  • Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy.

    Tetsuya Tomita;Eiji Takeuchi;Naruya Tomita;Ryuichi Morishita

  • Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.

    Y Taniyama;R Morishita;M Aoki;H Nakagami

  • Secreted phospholipase A2 revisited.

    Makoto Murakami;Yoshitaka Taketomi;Hiroyasu Sato;Kei Yamamoto

  • A new era of secreted phospholipase A2

    Makoto Murakami;Hiroyasu Sato;Yoshimi Miki;Kei Yamamoto

  • Receptor Heterodimerization: Essential Mechanism for Platelet-Derived Growth Factor-Induced Epidermal Growth Factor Receptor Transactivation

    Yuji Saito;Judith Haendeler;Yukihiro Hojo;Kei Yamamoto

  • Hypoxia-Induced Endothelial Apoptosis Through Nuclear Factor-κB (NF-κB)–Mediated bcl-2 Suppression In Vivo Evidence of the Importance of NF-κB in Endothelial Cell Regulation

    Hidetsugu Matsushita;Ryuichi Morishita;Toshie Nata;Motokuni Aoki

  • Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist

    Natsuo Ueda;Kei Yamamoto;Shozo Yamamoto;Takashi Tokunaga

  • Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells.

    Hironori Nakagami;Ryuichi Morishita;Kei Yamamoto;Shin Ichi Yoshimura

  • Mitogenic and Antiapoptotic Actions of Hepatocyte Growth Factor Through ERK, STAT3, and Akt in Endothelial Cells

    Hironori Nakagami;Ryuichi Morishita;Kei Yamamoto;Yoshiaki Taniyama

  • Potential Role of Hepatocyte Growth Factor, a Novel Angiogenic Growth Factor, in Peripheral Arterial Disease Downregulation of HGF in Response to Hypoxia in Vascular Cells

    Shin-ichiro Hayashi;Ryuichi Morishita;Shigefumi Nakamura;Kei Yamamoto

  • Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kappaB binding site as a novel molecular strategy.

    S Yoshimura;R Morishita;K Hayashi;K Yamamoto

  • In Vivo Administration of a Nuclear Transcription Factor-κB Decoy Suppresses Experimental Crescentic Glomerulonephritis

    Naruya Tomita;Ryuichi Morishita;Hui Y. Lan;Kei Yamamoto

  • Analyses of Group III Secreted Phospholipase A2 Transgenic Mice Reveal Potential Participation of This Enzyme in Plasma Lipoprotein Modification, Macrophage Foam Cell Formation, and Atherosclerosis *

    Hiroyasu Sato;Rina Kato;Yuki Isogai;Yuki Isogai;Go-ichi Saka

  • Emerging roles of secreted phospholipase A2 enzymes: Lessons from transgenic and knockout mice.

    Makoto Murakami;Yoshitaka Taketomi;Christophe Girard;Kei Yamamoto

  • Cyclic AMP Inhibited Proliferation of Human Aortic Vascular Smooth Muscle Cells, Accompanied by Induction of p53 and p21

    Shin-ichiro Hayashi;Ryuichi Morishita;Hidetsugu Matsushita;Hironori Nakagami

  • Inhibition of angiogenesis by humulone, a bitter acid from beer hop.

    Mariko Shimamura;Tadahiko Hazato;Hiromi Ashino;Yukio Yamamoto

  • Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators

    Yoshimi Miki;Yoshimi Miki;Kei Yamamoto;Yoshitaka Taketomi;Yoshitaka Taketomi;Hiroyasu Sato;Hiroyasu Sato

Frequent Co-Authors

Makoto Murakami
Makoto Murakami University of Tokyo
Ryuichi Morishita
Ryuichi Morishita Osaka University
Toshio Ogihara
Toshio Ogihara Osaka University
Yasufumi Kaneda
Yasufumi Kaneda Osaka University
Motokuni Aoki
Motokuni Aoki Morinomiya University of Medical Sciences
Shozo Yamamoto
Shozo Yamamoto Kyoto Women's University
Natsuo Ueda
Natsuo Ueda Kagawa University
Ryo Taguchi
Ryo Taguchi University of Tokyo
Toshikazu Nakamura
Toshikazu Nakamura Osaka University
Kunio Matsumoto
Kunio Matsumoto Kanazawa University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology or Biochemistry in the USA opens doors to diverse online degree and career options in healthcare and life sciences. Many students looking to enter nutrition or dietetics explore accelerated nutrition degree online programs. These options offer flexible and fast-paced coursework, ideal for those seeking to launch their careers sooner.

For graduates interested in leadership roles within healthcare, pursuing an online healthcare mba is a smart step. These programs emphasize management, strategy, and system administration, preparing students for supervisory and executive-level positions.

The rise of digital health records has also made medical coding a critical field. Prospective coders should understand the differences and value of medical coding certification, particularly when weighing CPC vs. CCS credentials, costs, and future salary prospects.

If you are curious about pay ranges in this industry, investigating the medical coder salary can guide your decision. As healthcare fields continue to grow, these pathways offer valuable, flexible, and rewarding career options for Biology and Biochemistry graduates.

Best Scientists Citing Kei Yamamoto

Trending Scientists

Recently Published Articles